$16.9 Billion is the total value of ARK Investment Management's 354 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Hyperfine Inc | $2,890 | -18.4% | 1,000,000 | 0.0% | 0.02% | +13.3% | ||
| XLE | Energy Select Sector SPDR Fundput | $1,735 | +14.1% | 19,900 | 0.0% | 0.01% | +66.7% | |
| ZM | Zoom Video Communications Inccall | $989 | -8.3% | 9,200 | 0.0% | 0.01% | +20.0% | |
| TSLA | Tesla Inccall | $303 | -29.7% | 400 | 0.0% | 0.00% | 0.0% | |
| ARKK | ARK Innovation ETFcall | $370 | -33.6% | 8,400 | 0.0% | 0.00% | 0.0% | |
| SQ | Block Inccall | $236 | -35.5% | 2,700 | 0.0% | 0.00% | -50.0% | |
| ROKU | Roku Inccall | $114 | -24.0% | 1,200 | 0.0% | 0.00% | 0.0% | |
| COIN | Coinbase Global Inccall | $172 | -58.9% | 2,200 | 0.0% | 0.00% | -50.0% | |
| TCS Group Holding PLCgdr | $0 | -100.0% | 608,351 | 0.0% | 0.00% | -100.0% | ||
| INTC | Intel Corpput | $62 | -10.1% | 1,400 | 0.0% | 0.00% | – | |
| ARKG | ARK Genomic Revolution ETFcall | $71 | -29.7% | 2,200 | 0.0% | 0.00% | – | |
| PACB | Pacific Biosciences of Califorcall | $41 | -37.9% | 7,200 | 0.0% | 0.00% | – | |
| CRSP | CRISPR Therapeutics AGcall | $75 | -8.5% | 1,300 | 0.0% | 0.00% | – | |
| Yeahka Ltd | $53 | -18.5% | 21,200 | 0.0% | 0.00% | – | ||
| AMD | Advanced Micro Devices Incput | $20 | -9.1% | 200 | 0.0% | 0.00% | – |
The following EDGAR filing(s) were analyzed to create this report:
The EDGAR filing(s) were signed by:
- Kellen Carter — Chief Compliance Officer
- ARK Investment Management holdings (13F-HR)
- ARK Investment Management significant holdings (13D/G)
- ARK Investment Management ownership history
- ARK Investment Management portfolio value
- ARK Investment Management filings
- Similar filers BETA
Compare quarterly holdings
Export ARK Investment Management's holdings